Literature DB >> 27571750

Crystal structure of Clostridium difficile toxin A.

Nicole M Chumbler1, Stacey A Rutherford2, Zhifen Zhang3, Melissa A Farrow2, John P Lisher4,5, Erik Farquhar6, David P Giedroc5, Benjamin W Spiller1,2,7, Roman A Melnyk3, D Borden Lacy1,2,8,9.   

Abstract

Clostridium difficile infection is the leading cause of hospital-acquired diarrhoea and pseudomembranous colitis. Disease is mediated by the actions of two toxins, TcdA and TcdB, which cause the diarrhoea, as well as inflammation and necrosis within the colon. The toxins are large (308 and 270 kDa, respectively), homologous (47% amino acid identity) glucosyltransferases that target small GTPases within the host. The multidomain toxins enter cells by receptor-mediated endocytosis and, upon exposure to the low pH of the endosome, insert into and deliver two enzymatic domains across the membrane. Eukaryotic inositol-hexakisphosphate (InsP6) binds an autoprocessing domain to activate a proteolysis event that releases the N-terminal glucosyltransferase domain into the cytosol. Here, we report the crystal structure of a 1,832-amino-acid fragment of TcdA (TcdA1832), which reveals a requirement for zinc in the mechanism of toxin autoprocessing and an extended delivery domain that serves as a scaffold for the hydrophobic α-helices involved in pH-dependent pore formation. A surface loop of the delivery domain whose sequence is strictly conserved among all large clostridial toxins is shown to be functionally important, and is highlighted for future efforts in the development of vaccines and novel therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27571750      PMCID: PMC4976693          DOI: 10.1038/nmicrobiol.2015.2

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN: 2058-5276            Impact factor:   17.745


  44 in total

1.  The complete receptor-binding domain of Clostridium difficile toxin A is required for endocytosis.

Authors:  Cornelia Frisch; Ralf Gerhard; Klaus Aktories; Fred Hofmann; Ingo Just
Journal:  Biochem Biophys Res Commun       Date:  2003-01-17       Impact factor: 3.575

2.  Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells.

Authors:  Maja Rupnik; Stefan Pabst; Marjan Rupnik; Christoph von Eichel-Streiber; Henning Urlaub; Hans-Dieter Söling
Journal:  Microbiology (Reading)       Date:  2005-01       Impact factor: 2.777

3.  The crystal structure of diphtheria toxin.

Authors:  S Choe; M J Bennett; G Fujii; P M Curmi; K A Kantardjieff; R J Collier; D Eisenberg
Journal:  Nature       Date:  1992-05-21       Impact factor: 49.962

4.  Comparative sequence analysis of the Clostridium difficile toxins A and B.

Authors:  C von Eichel-Streiber; R Laufenberg-Feldmann; S Sartingen; J Schulze; M Sauerborn
Journal:  Mol Gen Genet       Date:  1992-05

5.  Structure-function analysis of inositol hexakisphosphate-induced autoprocessing in Clostridium difficile toxin A.

Authors:  Rory N Pruitt; Benjamin Chagot; Michael Cover; Walter J Chazin; Ben Spiller; D Borden Lacy
Journal:  J Biol Chem       Date:  2009-06-24       Impact factor: 5.157

6.  Structural determinants for membrane insertion, pore formation and translocation of Clostridium difficile toxin B.

Authors:  Selda Genisyuerek; Panagiotis Papatheodorou; Gregor Guttenberg; Rolf Schubert; Roland Benz; Klaus Aktories
Journal:  Mol Microbiol       Date:  2011-01-28       Impact factor: 3.501

7.  Lysosomal involvement in cellular intoxication with Clostridium difficile toxin B.

Authors:  I Florin; M Thelestam
Journal:  Microb Pathog       Date:  1986-08       Impact factor: 3.738

8.  The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins.

Authors:  I Just; M Wilm; J Selzer; G Rex; C von Eichel-Streiber; M Mann; K Aktories
Journal:  J Biol Chem       Date:  1995-06-09       Impact factor: 5.157

9.  Defining an allosteric circuit in the cysteine protease domain of Clostridium difficile toxins.

Authors:  Aimee Shen; Patrick J Lupardus; Malte M Gersch; Aaron W Puri; Victoria E Albrow; K Christopher Garcia; Matthew Bogyo
Journal:  Nat Struct Mol Biol       Date:  2011-02-13       Impact factor: 15.369

10.  The combined repetitive oligopeptides of clostridium difficile toxin A counteract premature cleavage of the glucosyl-transferase domain by stabilizing protein conformation.

Authors:  Alexandra Olling; Corinna Hüls; Sebastian Goy; Mirco Müller; Simon Krooss; Isa Rudolf; Helma Tatge; Ralf Gerhard
Journal:  Toxins (Basel)       Date:  2014-07-22       Impact factor: 4.546

View more
  31 in total

1.  Deletion of a 19-Amino-Acid Region in Clostridioides difficile TcdB2 Results in Spontaneous Autoprocessing and Reduced Cell Binding and Provides a Nontoxic Immunogen for Vaccination.

Authors:  Sarah J Bland; Jason L Larabee; Tyler M Shadid; Mark L Lang; Jimmy D Ballard
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

2.  A neutralizing antibody that blocks delivery of the enzymatic cargo of Clostridium difficile toxin TcdB into host cells.

Authors:  Heather K Kroh; Ramyavardhanee Chandrasekaran; Zhifen Zhang; Kim Rosenthal; Rob Woods; Xiaofang Jin; Andrew C Nyborg; G Jonah Rainey; Paul Warrener; Roman A Melnyk; Benjamin W Spiller; D Borden Lacy
Journal:  J Biol Chem       Date:  2017-11-27       Impact factor: 5.157

3.  Use of a neutralizing antibody helps identify structural features critical for binding of Clostridium difficile toxin TcdA to the host cell surface.

Authors:  Heather K Kroh; Ramyavardhanee Chandrasekaran; Kim Rosenthal; Rob Woods; Xiaofang Jin; Melanie D Ohi; Andrew C Nyborg; G Jonah Rainey; Paul Warrener; Benjamin W Spiller; D Borden Lacy
Journal:  J Biol Chem       Date:  2017-07-13       Impact factor: 5.157

4.  Infection: Modulation of Clostridium difficile infection by dietary zinc.

Authors:  Anna M Seekatz; Vincent B Young
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-11-09       Impact factor: 46.802

5.  The chaperonin TRiC/CCT is essential for the action of bacterial glycosylating protein toxins like Clostridium difficile toxins A and B.

Authors:  Marcus Steinemann; Andreas Schlosser; Thomas Jank; Klaus Aktories
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-04       Impact factor: 11.205

6.  Functional defects in Clostridium difficile TcdB toxin uptake identify CSPG4 receptor-binding determinants.

Authors:  Pulkit Gupta; Zhifen Zhang; Seiji N Sugiman-Marangos; John Tam; Swetha Raman; Jean-Phillipe Julien; Heather K Kroh; D Borden Lacy; Nicholas Murgolo; Kavitha Bekkari; Alex G Therien; Lorraine D Hernandez; Roman A Melnyk
Journal:  J Biol Chem       Date:  2017-08-23       Impact factor: 5.157

7.  Holin-Dependent Secretion of the Large Clostridial Toxin TpeL by Clostridium perfringens.

Authors:  Angela Saadat; Stephen B Melville
Journal:  J Bacteriol       Date:  2021-03-23       Impact factor: 3.490

Review 8.  Clostridium difficile infection.

Authors:  Wiep Klaas Smits; Dena Lyras; D Borden Lacy; Mark H Wilcox; Ed J Kuijper
Journal:  Nat Rev Dis Primers       Date:  2016-04-07       Impact factor: 52.329

9.  The role of zinc and nutritional immunity in Clostridium difficile infection.

Authors:  Joseph P Zackular; Eric P Skaar
Journal:  Gut Microbes       Date:  2018-09-25

10.  Clostridium difficile Toxins TcdA and TcdB Cause Colonic Tissue Damage by Distinct Mechanisms.

Authors:  Nicole M Chumbler; Melissa A Farrow; Lynne A Lapierre; Jeffrey L Franklin; D Borden Lacy
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.